{"id":"https://openalex.org/W430350443","doi":null,"title":"PARP inhibitors for cancer treatment: an update on current clinical trials.","display_name":"PARP inhibitors for cancer treatment: an update on current clinical trials.","publication_year":2011,"publication_date":"2011-01-01","ids":{"openalex":"https://openalex.org/W430350443","mag":"430350443"},"language":"en","primary_location":{"id":"pmh:oai:art.torvergata.it:2108/51975","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2108/51975","pdf_url":null,"source":{"id":"https://openalex.org/S4306400993","display_name":"Cineca Institutional Research Information System (Tor Vergata University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I116067653","host_organization_name":"University of Rome Tor Vergata","host_organization_lineage":["https://openalex.org/I116067653"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/conferenceObject"},"volume":null,"type":"conference-paper","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036918847","display_name":"Grazia Graziani","orcid":"https://orcid.org/0000-0002-0221-768X","observed_orcids":["https://orcid.org/0000-0002-0221-768X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Grazia Graziani","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5084914939","display_name":"Lucio Tentori","orcid":"https://orcid.org/0000-0002-7691-527X","observed_orcids":["https://orcid.org/0000-0002-7691-527X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lucio Tentori","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.02894955,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":1.0},{"id":"https://openalex.org/keywords/poly-adp-ribose-polymerase","display_name":"poly(ADP-ribose) polymerase","score":0.9589999914169312},{"id":"https://openalex.org/keywords/brca1","display_name":"BRCA1","score":0.6389999985694885},{"id":"https://openalex.org/keywords/brca2","display_name":"BRCA2","score":0.9890000224113464},{"id":"https://openalex.org/keywords/synthetic-lethality","display_name":"synthetic lethality","score":0.8920000195503235},{"id":"https://openalex.org/keywords/homologous-recombination-deficiency","display_name":"homologous recombination deficiency","score":0.8870000243186951},{"id":"https://openalex.org/keywords/double-strand-break-repair","display_name":"DNA double-strand break repair","score":0.9139999747276306},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.8059999942779541},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9959999918937683},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9309999942779541},{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.9850000143051147},{"id":"https://openalex.org/keywords/hematologic-malignancies","display_name":"hematologic malignancies","score":0.9959999918937683},{"id":"https://openalex.org/keywords/temozolomide","display_name":"temozolomide","score":0.9020000100135803},{"id":"https://openalex.org/keywords/topoisomerase-i-inhibitor","display_name":"topoisomerase I inhibitor","score":0.8149999976158142},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.48399999737739563},{"id":"https://openalex.org/keywords/radiotherapy","display_name":"radiotherapy","score":0.7950000166893005}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6880927681922913},{"id":"https://openalex.org/C2778502085","wikidata":"https://www.wikidata.org/wiki/Q7662767","display_name":"Synthetic lethality","level":4,"score":0.6403859853744507},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.627579927444458},{"id":"https://openalex.org/C2779012473","wikidata":"https://www.wikidata.org/wiki/Q3235015","display_name":"RAD51","level":4,"score":0.5634490251541138},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5057826042175293},{"id":"https://openalex.org/C2779138821","wikidata":"https://www.wikidata.org/wiki/Q7118227","display_name":"PARP inhibitor","level":5,"score":0.49926137924194336},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4983537197113037},{"id":"https://openalex.org/C134935766","wikidata":"https://www.wikidata.org/wiki/Q210538","display_name":"DNA repair","level":3,"score":0.47783565521240234},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.45466652512550354},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.4434933364391327},{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.3315327763557434},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.27153098583221436},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.24281790852546692},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.2274378538131714},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.09412607550621033}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:art.torvergata.it:2108/51975","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2108/51975","pdf_url":null,"source":{"id":"https://openalex.org/S4306400993","display_name":"Cineca Institutional Research Information System (Tor Vergata University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I116067653","host_organization_name":"University of Rome Tor Vergata","host_organization_lineage":["https://openalex.org/I116067653"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/conferenceObject"},{"id":"mag:430350443","doi":null,"is_oa":false,"landing_page_url":"https://art.torvergata.it/handle/2108/51975","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W960041760","https://openalex.org/W2157060862","https://openalex.org/W2766552679","https://openalex.org/W2902159788","https://openalex.org/W2300265398","https://openalex.org/W2781223059","https://openalex.org/W1993119044","https://openalex.org/W2802157782","https://openalex.org/W1972869110","https://openalex.org/W2981233955"],"abstract_inverted_index":{"Poly(ADP-ribose)":[0],"polymerase":[1],"(PARP)":[2],"inhibitors":[3,33,160,187],"are":[4,45,129,193],"a":[5,169,201],"promising":[6],"class":[7],"of":[8,53,64,76,89,121,145,158,200,203],"anticancer":[9],"agents":[10,39],"to":[11,73,174],"be":[12,153],"used":[13],"either":[14],"alone":[15],"or":[16,69,96,192],"in":[17,40,47,61,142,161],"combination":[18],"with":[19,100,117,185],"chemotherapy":[20],"(e.g.,":[21],"the":[22,48,65,74,90,112,118,156,166,198],"methylating":[23],"compound":[24],"temozolomide,":[25],"topoisomerase":[26],"I":[27],"poisons)":[28],"and":[29,82,181,216,224],"radiotherapy.":[30],"Moreover,":[31],"PARP":[32,101,127,133,159,186],"exert":[34],"cytotoxic":[35,109],"effects":[36],"as":[37,80,103,148],"single":[38,104,122],"BRCA":[41,92,146,162],"mutated":[42],"tumours,":[43,206],"which":[44,85],"defective":[46],"homologous":[49],"recombination":[50],"(HR)":[51],"repair":[52],"DNA":[54],"double":[55],"strand":[56,123],"breaks":[57,124],"(DSBs).":[58],"Germline":[59],"mutations":[60,141],"one":[62],"allele":[63],"tumour":[66,138],"suppressor":[67],"BRCA1":[68],"BRCA2":[70],"genes":[71],"predispose":[72],"development":[75],"several":[77],"cancers,":[78],"such":[79],"breast":[81,218],"ovarian":[83,208],"cancers":[84],"arise":[86],"after":[87,115],"inactivation":[88],"remaining":[91],"allele.":[93],"In":[94],"normal":[95],"heterozygous":[97],"cells,":[98],"treatment":[99,199],"inhibitor":[102],"agent":[105],"does":[106],"not":[107],"cause":[108],"effects,":[110],"since":[111],"DSBs,":[113],"generated":[114],"collision":[116],"replication":[119],"fork":[120],"deriving":[125],"from":[126],"inhibition,":[128],"repaired":[130],"by":[131],"HR.":[132],"inhibitors,":[134],"instead,":[135],"selectively":[136],"kill":[137],"cells":[139],"carrying":[140],"both":[143],"alleles":[144],"genes,":[147],"DSBs":[149],"can":[150],"no":[151],"longer":[152],"repaired.":[154],"Therefore,":[155],"use":[157],"deficient":[163],"tumours":[164],"provides":[165],"basis":[167],"for":[168,197],"novel":[170],"\u201csynthetic":[171],"lethal\u201d":[172],"approach":[173],"cancer":[175],"treatment.":[176],"\\nMany":[177],"phase":[178],"I,":[179],"II":[180],"III":[182],"clinical":[183],"studies":[184],"have":[188],"been":[189],"recently":[190],"completed":[191],"currently":[194],"recruiting":[195],"patients":[196],"variety":[202],"advanced":[204],"solid":[205],"including":[207],"cancer,":[209,219,223],"triple-negative":[210],"(i.e.,":[211],"estrogen":[212],"receptor-negative,":[213],"progesterone":[214],"receptor-negative":[215],"HER2-negative)":[217],"melanoma,":[220],"glioblastoma,":[221],"colorectal":[222],"haematological":[225],"malignancies.":[226]},"counts_by_year":[],"updated_date":"2026-08-21T09:56:20.448147","created_date":"2016-06-24T00:00:00"}